Era7 Bioinformatics

Executive Summary

Era7 Bioinformatics, founded in 2010 and headquartered in Granada, Spain, specializes in bacterial genomics and bioinformatics services, including genome annotation, comparative genomics, and metagenomics. Leveraging open-source platforms and cloud computing, the company delivers research-driven solutions for next-generation sequencing data analysis. Despite a long operating history, Era7 remains a private entity with no disclosed funding rounds or valuation, and limited public profile. The company's niche focus on bacterial genomics positions it well in the growing bioinformatics market, particularly as antimicrobial resistance and microbiome research gain traction. However, its lack of commercial product visibility and modest engagement scores suggest a conservative growth trajectory. The conviction score reflects moderate confidence given the company's established expertise but limited near-term growth signals.

Upcoming Catalysts (preview)

• TBDLaunch of AI-powered genome annotation platform60% success
• TBDStrategic partnership with a pharmaceutical or diagnostics company40% success